Introduction {#Sec1}
============

Isoflavonoids are a large group of secondary metabolites with diverse biological activities that occur widely in plants, which can be subdivided into isoflavones, isoflavans, isoflavanones, rotenoids, pterocarpans, etc. An overwhelming number of isoflavonoids reported come from the Leguminosae family, and some non-leguminous families such as Moraceae are also relatively abundant in isoflavonoids \[[@CR1], [@CR2]\]. Some isoflavans and prenylated isoflavones possess potent biological activities, especially in cytotoxicity \[[@CR3]--[@CR6]\], anti-inflammatory \[[@CR7]\], and neuroprotective activity \[[@CR8]\]. As part of a BioBioPha (<http://www.chemlib.cn>) objective to assemble a large-scale natural product library valuable in the discovery of new drug leads from nature \[[@CR9]--[@CR12]\], the phytochemical investigations on *Spatholobus suberectus* (Leguminosae), *Flemingia macrophylla* (Leguminosae), and *Cudrania cochinchinensis* (Moraceae) led to the isolation of three new isoflavans 7,4′-dihydroxy-8,2′,3′-trimethoxyisoflavan (**1**), 7,2′,4′-trihydroxy-8,3′-dimethoxyisoflavan (**2**), and 7,2′,4′-trihydroxy-5-methoxyisoflavan (**3**), and one new prenylated isoflavone namely cudraisoflavone M (**4**), respectively (Fig. [1](#Fig1){ref-type="fig"}). Herein we report the structure elucidation of new isoflavonoid and their cytotoxicity evaluation against five human cancer cell lines (HL-60, A-549, SMMC-7721, MCF-7, and SW-480).Fig. 1Structures of new compounds **1**--**4**

Results and Discussion {#Sec2}
======================

Compound **1** was obtained as white amorphous powder, and its molecular formula was determined to be C~18~H~20~O~6~ from the positive HRESIMS at *m*/*z* 355.1163 \[M+Na\]^+^ (calcd. for C~18~H~20~O~6~Na, 355.1158) with nine degrees of unsaturation. The ^1^H NMR spectrum (Table [1](#Tab1){ref-type="table"}) displayed five aliphatic proton signals due to two methylene groups \[*δ* ~H~ 2.86 (1H, ddd, *J* = 15.8, 5.3, 1.9 Hz) and 2.94 (1H, dd, *J* = 15.8, 11.3 Hz), 4.00 (1H, t, *J* = 10.5 Hz) and 4.37 (1H, ddd, *J* = 10.5, 3.7, 1.9 Hz)\], and one methine \[*δ* ~H~ 3.53 (1H, dddd, *J* = 11.3, 10.5, 5.3, 3.7 Hz)\], which were characteristic of an isoflavan \[[@CR13]\]. The ^1^H NMR spectrum also exhibited two pairs of *ortho*-coupled aromatic doublets \[*δ* ~H~ 6.52 (1H, d, *J* = 8.3 Hz), 6.72 (1H, d, *J* = 8.3 Hz), 6.71 (1H, d, *J* = 8.5 Hz), and 6.75 (1H, d, *J* = 8.5 Hz)\], three methoxy groups \[*δ* ~H~ 3.87, 3.92 and 3.93 (each 3H, s)\], and two phenolic hydroxy protons \[*δ* ~H~ 5.66 and 5.71 (each 1H, s)\]. The ^13^C NMR spectrum (Table [2](#Tab2){ref-type="table"}) showed a total of 18 carbon signals, including 12 aromatic carbons for two phenyl units (rings A and B), the ring C carbons at *δ* ~C~ 31.4 (d), 31.5 (t), 70.5 (t), and three methoxy carbons at *δ* ~C~ 60.6, 60.8, 61.0 (each q). The above NMR spectroscopic features were very similar to those of isoduartin (=7,2′-dihydroxy-8,3′,4′-trimethoxyisoflavan) \[[@CR14]\], except for an obvious downfield shift for H-5′ (Δ = +0.27 ppm), which hinted a different substituted pattern in ring B. The pattern can be determined as 4′-hydroxy-2′,3′-dimethoxy by the following HMBC correlations (Fig. [2](#Fig2){ref-type="fig"}): from 4′-OH (*δ* ~H~ 5.71) to C-3′ (*δ* ~C~ 139.8), C-4′ (*δ* ~C~ 148.5) and C-5′ (*δ* ~C~ 110.5); from H-3 (*δ* ~H~ 3.53) and 2′-OCH~3~ (*δ* ~H~ 3.87) to C-2′ (*δ* ~C~ 150.8); and from 3′-OCH~3~ (*δ* ~H~ 3.93) to C-3′. The particular downfield shifts (Δ ≈ +5 ppm) of aromatic methoxy carbons also implied the location of these groups. According to the empirical rule, the carbon signals of the methoxy groups with substituents in both *ortho* positions will appear at 60--62 ppm, while those sterically non-hindered at 55--57 ppm \[[@CR15]\]. On the basis of the above analysis, the structure of **1** was established as 7,4′-dihydroxy-8,2′,3′-trimethoxyisoflavan.Table 1^1^H NMR spectroscopic data of compounds **1**--**3**No.**1** ^a^**2** ^a^**3** ^b^2-H~*eq*~4.37 (ddd, 10.5, 3.7, 1.9)4.43 (ddd, 10.2, 3.4, 2.0)4.16 (ddd, 10.2, 3.1, 1.9)2-H~*ax*~4.00 (dd, 10.5, 10.5)4.07 (dd, 10.2, 10.2)3.86 (dd, 10.2, 10.2)33.53 (dddd, 11.3, 10.5, 5.3, 3.7)3.52 (dddd, 10.9, 10.2, 5.3, 3.4)3.34 (dddd, 10.8, 10.2, 5.5, 3.1)4-H~*ax*~2.94 (dd, 15.8, 11.3)3.01 (dd, 15.8, 10.9)2.59 (dd, 16.3, 10.8)4-H~*eq*~2.86 (ddd, 15.8, 5.3, 1.9)2.90 (ddd, 15.8, 5.3, 2.0)2.76 (ddd, 16.3, 5.5, 1.9)56.72 (d, 8.3)6.72 (d, 8.3)66.52 (d, 8.3)6.52 (d, 8.3)5.99 (d, 2.1)85.88 (d, 2.1)3′6.30 (d, 2.4)5′6.71 (d, 8.5)6.47 (d, 8.5)6.24 (dd, 8.3, 2.4)6′6.75 (d, 8.5)6.74 (d, 8.5)6.85 (d, 8.3)7-OH5.66 (s)5.69 (s)2′-OH5.72 (s)4′-OH5.71 (s)5.30 (br s)5-OCH~3~3.74 (s)8-OCH~3~3.92 (s)3.91 (s)2′-OCH~3~3.87 (s)3′-OCH~3~3.93 (s)3.88 (s)^a^Measured in CDCl~3~ (*δ* ~H~ 7.26 ppm)^b^Measured in CD~3~OD (*δ* ~H~ 3.30 ppm) Table 2^13^C NMR spectroscopic data of compounds **1**--**3**No.**1** ^a^**2** ^a^**3** ^b^270.5 (t)69.8 (t)71.0 (t)331.4 (d)31.8 (d)32.6 (d)431.5 (t)30.3 (t)26.1 (t)5124.3 (d)124.3 (d)160.1 (s)6107.0 (d)106.9 (d)92.3 (d)7147.5 (s)147.4 (s)157.7 (s)8134.8 (s)134.7 (s)96.5 (d)9147.1 (s)147.1 (s)156.9 (s)10115.3 (s)115.3 (s)104.1 (s)1′126.3 (s)119.9 (s)120.4 (s)2′150.8 (s)147.1 (s)157.2 (s)3′139.8 (s)134.5 (s)103.5 (d)4′148.5 (s)147.4 (s)157.9 (s)5′110.5 (d)107.8 (d)107.6 (d)6′122.0 (d)122.7 (d)128.8 (d)5-OCH~3~55.8 (q)8-OCH~3~61.0 (q)60.9 (q)2′-OCH~3~60.8 (q)3′-OCH~3~60.6 (q)61.2 (q)^a^Measured in CDCl~3~ (*δ* ~C~ 77.0 ppm)^b^Measured in CD~3~OD (*δ* ~C~ 49.0 ppm) Fig. 2Key HMBC (![](13659_2017_121_Figb_HTML.gif){#d29e1233}) correlations of **1**--**4**

Compound **2**, isolated as white amorphous powder, had a molecular formula of C~17~H~18~O~6~ by the positive HRESIMS at *m*/*z* 341.1002 \[M+Na\]^+^ (calcd. for C~17~H~18~O~6~Na, 341.1001). Comparison of the ^1^H and ^13^C NMR spectral data (Tables [1](#Tab1){ref-type="table"}, [2](#Tab2){ref-type="table"}) with those of **1** revealed that a methoxy group in the ring B was replaced by a hydroxy. From the HMBC correlations of the OH signal at *δ* ~H~ 5.72 (1H, s) to C-1′ (*δ* ~C~ 119.9), C-2′ (*δ* ~C~ 147.1), and C-3′ (*δ* ~C~ 134.5), we could conclude that the emerging hydroxy was positioned at C-2′ (Fig. [2](#Fig2){ref-type="fig"}). Hence, the structure of **2** was established as 7,2′,4′-trihydroxy-8,3′-dimethoxyisoflavan.

Compound **3** was isolated as white amorphous powder, and its molecular formula was determined to be C~16~H~16~O~5~ according to the positive HRESIMS at *m*/*z* 289.1075 \[M+H\]^+^ (calcd. for C~16~H~17~O~5~, 289.1076). Five diagnostic ring C proton signals \[*δ* ~H~ 2.59 (1H, dd, *J* = 16.3, 10.8 Hz), 2.76 (1H, ddd, *J* = 16.3, 5.5, 1.9 Hz), 3.34 (1H, dddd, *J* = 10.8, 10.2, 5.5, 3.1 Hz), 3.86 (1H, dd, *J* = 10.2, 10.2 Hz), and 4.16 (1H, ddd, *J* = 10.2, 3.1, 1.9 Hz)\], an ABX-type aromatic proton system \[*δ* ~H~ 6.30 (1H, d, *J* = 2.4 Hz), 6.24 (1H, dd, *J* = 8.3, 2.4 Hz), and 6.85 (1H, d, *J* = 8.3 Hz)\], two *meta*-coupled aromatic doublets \[*δ* ~H~ 5.88 (1H, d, *J* = 2.1 Hz) and 5.99 (1H, d, *J* = 2.1 Hz)\], and one methoxy signal \[*δ* ~H~ 3.74 (3H, s)\] were observed in the ^1^H NMR spectrum (Table [1](#Tab1){ref-type="table"}), which revealed that **3** was a monomethyl ether derivative of 5,7,2′,4′-tetrahydroxyisoflavan. The HMBC correlations from the methoxy and H-4 proton signals to C-5 (*δ* ~C~ 160.1) confirmed the methoxy group at C-5 (Fig. [2](#Fig2){ref-type="fig"}). Therefore, the structure of **3** was established as 7,2′,4′-trihydroxy-5-methoxyisoflavan.

Absolute configurations of the isoflavans (**1**--**3**) were established by comparison of the CD curves with those reported earlier for closely related analogues. All the CD spectra showed a negative Cotton effect in the transition region (215--240 nm), similar with those of 7-*O*-methylisomucronulatol, (3*R*)-isomucronulatol, and abruquinone L \[[@CR16]--[@CR19]\], which indicated the absolute configurations at C-3 of **1**--**3** being *R*-form. And optical rotation measurements were also taken to assign the absolute configuration. We carefully examined the specific rotation values of some 2′,3′,4′-trisubstituted isoflavans (Table [3](#Tab3){ref-type="table"}), and the results suggested that the methoxy group substituted at C-2′ had a huge impact on the specific rotation, probably on account of the spatial proximity. For 2′-methoxyisoflavans, *R*-/*S*-form result in positive/negative specific rotation values, respectively, but for 2′-hydroxyisoflavans, *R*-form gives negative values \[[@CR14], [@CR17], [@CR20]--[@CR25]\]. Our current research results were consistent with the above empirical rule.Table 3Specific rotation values of some 2′,3′,4′-trisubstituted isoflavansCompoundSubstitution pattern\[*α*\]~D~References36782′3′4′(−)-Duartin*S*--OHOMeOMeOHOMe−18.5 (CHCl~3~)\[[@CR20]\]Mucronulatol*S*--OH--OMeOHOMe−18.5 (Me~2~CO)\[[@CR21]\]Bryaflavan*S*OHOH--OMeOHOMe−17.3 (MeOH)\[[@CR22]\]2′-*O*-Methylisomucronulatol*R*--OH--OMeOMeOMe+6.5 (CHCl~3~)\[[@CR23]\](+)-Duartin*R*--OHOMeOMeOHOMe+3.4 (CHCl~3~)\[[@CR14]\]8,3′-Dihydroxyvestitol*R*--OHOHOHOHOMe−5.2 (MeOH)\[[@CR24]\]Isomucronulatol*R*--OH--OHOMeOMe−19.4 (EtOH)\[[@CR25]\]7-*O*-Methylisomucronulatol*R*--OMe--OHOMeOMe−11.0 (CHCl~3~)\[[@CR17]\]

Compound **4**, yellowish amorphous powder, had a molecular formula of C~22~H~22~O~7~ according to the positive HRESIMS at *m*/*z* 399.1440 \[M+H\]^+^ (calcd. for C~22~H~23~O~7~, 399.1444). The NMR spectra (Table [4](#Tab4){ref-type="table"}) showed an olefinic signal (*δ* ~H~ 8.23, 1H, s; *δ* ~C~ 154.3, d) and a chelated hydroxy group at *δ* ~H~ 13.48 (1H, s), characteristic of a 5-hydroxyisoflavone skeleton \[[@CR8], [@CR13]\]. In addition, an ABX-type aromatic proton system \[*δ* ~H~ 7.15 (1H, d, *J* = 2.0 Hz), 6.86 (1H, d, *J* = 8.2 Hz), and 6.94 (1H, dd, *J* = 8.2, 2.0 Hz)\], a prenyl group \[*δ* ~H~ 1.63, 1.79 (each 3H, s), 3.45 (2H, d, *J* = 7.1 Hz), and 5.22 (1H, br t, *J* = 7.1 Hz)\], and a hydroxyethyl moiety \[*δ* ~H~ 2.97, 3.90 (each 2H, t, *J* = 5.2 Hz)\] were also detected in the ^1^H NMR spectrum. The ^13^C NMR spectrum displayed a total of 22 carbon resonances, including two methyls, three *sp* ^3^ methylenes, five *sp* ^2^ methines, and 12 *sp* ^2^ quaternary carbons. These spectroscopic features were very similar to those of cudraisoflavone L, which was recently isolated from the same genus and shared the same molecular formula with **4** \[[@CR26]\]. Their structural difference was only due to the location of the prenyl group and the hydroxyethyl moiety. The hydroxyethyl unit was located at C-6 from the HMBC correlations of H-1″ (*δ* ~H~ 2.97) and 5-OH (*δ* ~H~ 13.48) to C-5 (*δ* ~C~ 158.5) and C-6 (*δ* ~C~ 111.2), while the prenyl group at C-8 by the correlations of H-1‴ (*δ* ~H~ 3.45) and H-2 (*δ* ~H~ 8.23) to C-9 (*δ* ~C~ 154.6). Thus the structure of **4** was established and named as cudraisoflavone M. It is worth mentioning that cudraisoflavone M (**4**) was also obtained in our phytochemical investigation on the plant *Derris robusta* (Leguminosae).Table 4NMR spectroscopic data of cudraisoflavone M (**4**) in acetone-*d* ~6~ (*δ* ~H~ 2.04 ppm, *δ* ~C~ 29.8 ppm)No.*δ* ~H~*δ* ~C~No.*δ* ~H~*δ* ~C~28.23 (s)154.3 (d)4′146.1 (s)3123.5 (s)5′6.86 (d, 8.2)115.8 (d)4182.0 (s)6′6.94 (dd, 8.2, 2.0)121.4 (d)5158.5 (s)1′′2.97 (t, 5.2)26.1 (t)6111.2 (s)2″3.90 (t, 5.2)63.7 (t)7161.8 (s)1‴3.45 (d, 7.1)22.4 (t)8107.7 (s)2‴5.22 (br t, 7.1)123.3 (d)9154.6 (s)3‴131.8 (s)10105.8 (s)4‴1.63 (s)25.8 (q)1′123.8 (s)5‴1.79 (s)17.9 (q)2′7.15 (d, 2.0)117.2 (d)5-OH13.48 (s)3′145.5 (s)

Considering the potent cytotoxic activity of some isoflavonoids, the cytotoxicity of these new isoflavonoids (**1**--**4**) was evaluated against five human cancer cell lines (HL-60, A-549, SMMC-7721, MCF-7, and SW-480) using the MTS method. DDP (cisplatin) and paclitaxel were used as positive controls. The results showed that **1** and **4** exhibited weak cytotoxic activity (Table [5](#Tab5){ref-type="table"}), while **2** and **3** were inactive (IC~50~ values \>40 µM) for all cell lines.Table 5Cytotoxic activities of compounds **1**--**4** against five human cancer cell linesCompd.HL-60A-549SMMC-7721MCF-7SW-480**1**19.27\>4019.1139.72\>40**4**20.6018.7725.2524.3024.53DDP1.4922.3018.6030.1020.50Paclitaxel\<0.008\<0.008\<0.008\<0.008\<0.008

Experimental Section {#Sec3}
====================

General Experimental Procedures {#Sec4}
-------------------------------

Optical rotations were measured on Jasco P-1020 automatic digital polarimeter. CD spectra were recorded on a Chirascan spectropolarimeter (Applied Photophysics, Leatherhead, Surrey, UK). UV data were obtained from HPLC online analysis. IR spectra were obtained on a Bruker Tensor-27 infrared spectrophotometer with KBr pellets. NMR spectra were carried out on a Bruker Avance III 600 or DRX-500 spectrometer with deuterated solvent signals used as internal standards. ESIMS and HRESIMS were measured using Agilent G6230 time-of-flight mass spectrometer. Preparative MPLC was performed on a Büchi apparatus equipped with Büchi fraction collector C-660, Büchi pump module C-605 and manager C-615. Silica gel (200--300 mesh, Qingdao Marine Chemical Inc., China), MCI gel CHP-20P (75--150 μm, Mitsubishi Chemical Corporation, Japan), Chromatorex C-18 (40--75 μm, Fuji Silysia Chemical Ltd., Japan) and Sephadex LH-20 (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) were used for column chromatography. Fractions were monitored and analyzed using TLC, in combination with an Agilent 1200 series HPLC system equipped by an Extend-C18 column (5 μm, 4.6 × 150 mm).

Plant Material and Isolation (Table [6](#Tab6){ref-type="table"}) {#Sec5}
-----------------------------------------------------------------

The retention times (*t* ~R~) of **1**--**4** on an analytical HPLC Extend-C18 column (20% → 100% MeOH in H~2~O over 8.0 min followed by 100% MeOH to 13.0 min, 1.0 mL/min, 25 °C) were 7.51, 6.85, 6.61 and 9.12 min, respectively.Table 6Plant material and isolation

### 7,4′-Dihydroxy-8,2′,3′-trimethoxyisoflavan (**1**) {#Sec6}

White amorphous powder; UV (MeOH) *λ* ~max~: 228 (sh), 278 nm; \[*α*\]~D~^25^ +11.0 (*c* 0.20, MeOH); IR (KBr) *ν* ~max~: 3396, 2944, 1602, 1497, 1464, 1292, 1198, 1170, 1097, 1068, 1040, 1010, 963 cm^−1^; ^1^H NMR data: see Table [1](#Tab1){ref-type="table"}; ^13^C NMR data: see Table [2](#Tab2){ref-type="table"}; ESIMS (pos.): *m*/*z* 355 \[M+Na\]^+^; HRESIMS (pos.): *m*/*z* 355.1163 \[M+Na\]^+^ (calcd. for C~18~H~20~O~6~Na, 355.1158).

### 7,2′,4′-Trihydroxy-8,3′-dimethoxyisoflavan (**2**) {#Sec7}

White amorphous powder; UV (MeOH) *λ* ~max~: 229 (sh), 277 nm; \[*α*\]~D~^25^ −13.2 (*c* 0.20, MeOH); IR (KBr) *ν* ~max~: 3404, 2929, 1619, 1509, 1470, 1328, 1184, 1091, 1058, 1037, 1001, 804 cm^−1^; ^1^H NMR data: see Table [1](#Tab1){ref-type="table"}; ^13^C NMR data: see Table [2](#Tab2){ref-type="table"}; ESIMS (pos.): *m*/*z* 341 \[M+Na\]^+^; HRESIMS (pos.): *m*/*z* 341.1002 \[M+Na\]^+^ (calcd. for C~17~H~18~O~6~Na, 341.1001).

### 7,2′,4′-Trihydroxy-5-methoxyisoflavan (**3**) {#Sec8}

White amorphous powder; UV (MeOH) *λ* ~max~: 230 (sh), 279 nm; \[*α*\]~D~^25^ −24.0 (*c* 0.20, MeOH); IR (KBr) *ν* ~max~: 3406, 2937, 1620, 1606, 1520, 1501, 1472, 1459, 1200, 1142, 1118, 1037, 974, 819 cm^−1^; ^1^H NMR data: see Table [1](#Tab1){ref-type="table"}; ^13^C NMR data: see Table [2](#Tab2){ref-type="table"}; ESIMS (pos.): *m*/*z* 289 \[M+H\]^+^; HRESIMS (pos.): *m*/*z* 289.1075 \[M+H\]^+^ (calcd. for C~16~H~17~O~5~, 289.1076).

### Cudraisoflavone M (**4**) {#Sec9}

Yellowish amorphous powder; UV (MeOH) *λ* ~max~: 212, 270, 346 (sh) nm; IR (KBr) *ν* ~max~: 3425, 2926, 1644, 1582, 1522, 1435, 1380, 1306, 1209, 1116, 1083, 1030 cm^−1^; ^1^H and ^13^C NMR data: see Table [4](#Tab4){ref-type="table"}; ESIMS (pos.): *m*/*z* 399 \[M+H\]^+^; HRESIMS (pos.): *m*/*z* 399.1440 \[M+H\]^+^ (calcd. for C~22~H~23~O~7~, 399.1444).

Cytotoxicity Assays {#Sec10}
-------------------

Five human tumor cell lines (HL-60, A-549, SMMC-7721, MCF-7, and SW-480) obtained from ATCC (Manassas, VA, USA) were used in the cytotoxicity assay. All cells were cultured in RPMI-1640 or DMEM medium (Hyclone, Logan, UT, USA), supplemented with 10% fetal bovine serum (Hyclone) at 37 °C in a humidified atmosphere containing 5% CO~2~. Cell viability was assessed by conducting colorimetric measurements of the amount of insoluble formazan formed in living cells based on the reduction of MTS (Sigma, St. Louis, MO, USA). Briefly, 100 μL of adherent cells were seeded into each well of a 96-well cell culture plate and allowed to adhere for 12 h before drug addition, while suspended cells were seeded just before drug addition, both with an initial density of 1 × 10^5^ cells/mL in 100 μL medium. Each cell line was exposed to the test compound at various concentrations in triplicate for 48 h, with cisplatin and paclitaxel as positive controls. After the incubation, 20 μL MTS and 100 μL medium was added to each well after removal of 100 μL medium, and the incubation continued for 2--4 h at 37 °C. The optical density was measured at 492 nm using a Multiskan FC plate reader (Thermo Scientific, USA). The IC~50~ value of each compound was calculated according to the Reed and Muench method.
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